Pharmerging Market to Expand at a Highly Optimistic CAGR of 11.30% Within a Forecast Period from 2016 to 2024
Analysts have pegged the global pharmerging market to expand at a highly optimistic CAGR of 11.30% within a forecast period from 2016 to 2024, owing to several drivers such as the increasing demand for pharma products overall. The market is expected to reach US$1.40 bn by the end of 2024, after being evaluated at US$552.80 mn in 2015.
View full press release